Browse by:

Sevcon closes $10M rights offering

John Agoglia |

Southborough-based Sevcon Inc., which designs and manufacturers controls for electric and hybrid vehicles, has closed its $10 million rights offering to its shareholders, the company said Wednesday.

Lightower expands Philadelphia network

John Agoglia |

Boxborough-based Lightower Fiber Networks said it’s expanding its all-fiber network in downtown Philadelphia.

Marlborough's ReWalk closes IPO

John Agoglia |

ReWalk Robotics of Marlborough said it had closed its initial public offering of 3.45 million shares of stock, which includes 3 million offered on Monday and an additional 450,000 offered through an...

RXi wins new patents

Emily Micucci |

RXi Pharmaceuticals Corp. of Marlborough said it has received a new patent on a delivery system for the treatment diseases with an inflammatory component.

BSX system awarded EU approval

Emily Micucci |

Marlborough-based Boston Scientific Corp. (BSX) has received approval to sell its system designed to treat tremor disorders in the European Union, the company announced Wednesday.

Grant issued for Worcester downtown incubator

Emily Micucci |

The Worcester-based Institute for Environmental Sustainability (IES) has been awarded a $125,000 grant to help establish an incubator in downtown Worcester, the Massachusetts Clean Energy Center...

SanDisk to officially open Marlborough facility

SanDisk will open a new 60,000-square-foot research and development facility in Marlborough on Thursday with a ceremony featuring the company’s co-founder and local officials.

New Jersey ACO hires eClinical to manage records

Emily Micucci |

Westborough-based healthcare IT company eClinicalWorks will provide electronic medical records management to the New Jersey Physicians Accountable Care Organization (ACO), a group of more than 37...

ReWalk shares up 13% on first day of IPO

Rick Saia |

Shares of stock in ReWalk Robotics of Marlborough gained more than 13 percent Friday, the same day the manufacturer of robotic exoskeletons for people with spinal cord injuries launched its initial...

Abbvie reports on Humira study for chronic skin disease

John Agoglia |

AbbVie, a Chicago-based company with a research and development facility in Worcester, announced Thursday that results from a Phase 3 study demonstrate that its arthritis drug, Humira is...

Copyright 2014 New England Business Media